SCHEMBL6286711

SCHEMBL6286711

CC(C)(C)OC(=O)NCCCC[C@](N)(C(=O)Cc1c[nH]c2ccccc12)C(=O)Nc1ccc(N(c2ccc(NC(=O)[C@](N)(CCCCNC(=O)OC(C)(C)C)C(=O)Cc3c[nH]c4ccccc34)cc2)c2ccc(NC(=O)[C@](N)(CCCCNC(=O)OC(C)(C)C)C(=O)Cc3c[nH]c4ccccc34)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 2/20 0.42
HRH3 Q9Y5N1 1/20 0.41
CTSL P07711 1/20 0.40
CTSS P25774 1/20 0.40
CTSK P43235 1/20 0.40
GOT1 P17174 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TERT O14746 2/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MAPT P10636 3/20 0.38
TP53 P04637 1/20 0.38
TACR1 P25103 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6287996 0.91 CTSL (0.41) CAMK2DCTSLCTSSCTSKGOT1
SCHEMBL6287290 0.83 GOT1 (0.42) CAMK2DCTSLCTSSCTSKGOT1
SCHEMBL6291033 0.82 MAPT (0.45) CAMK2DCTSLCTSSCTSKGOT1
SCHEMBL7036790 0.81 TRPV1 (0.41) ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL6284180 0.80 MC3R (0.44) HRH3GOT1
SCHEMBL6290422 0.80 CAMK2D (0.42) CAMK2DGOT1CA1CA2HDAC3
SCHEMBL6290282 0.80 ANO1 (0.39) CA1CA2MAPT
SCHEMBL6284135 0.79 MAPT (0.43) HRH3ALDH1A1MAPTTP53MEN1
SCHEMBL6287427 0.79 MEN1 (0.47) HRH3GOT1ALDH1A1MAPTL3MBTL1
SCHEMBL6287580 0.79 TRPM8 (0.47) MAPTHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK CAMK2D 3521/4885HRH3 2351/4885CTSL 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.